These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10365105)

  • 1. Expression of Bcl-2, Bax, and p53 proteins in carcinogenesis of squamous cell lung cancer.
    Chen Y; Sato M; Fujimura S; Endo C; Sakurada A; Aikawa H; Takahashi H; Tanita T; Kondo T; Saito Y; Sagawa M
    Anticancer Res; 1999; 19(2B):1351-6. PubMed ID: 10365105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and Bcl-2 expression in pneumoconiosis-related pre-cancerous lesions and lung cancers: frequent and preferential p53 expression in pneumoconiotic bronchiolar dysplasias.
    Katabami M; Dosaka-Akita H; Honma K; Kimura K; Fujino M; Uchida Y; Mikami H; Ohsaki Y; Kawakami Y; Kikuchi K
    Int J Cancer; 1998 Feb; 75(4):504-11. PubMed ID: 9466648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium.
    Törmänen U; Nuorva K; Soini Y; Pääkkö P
    Br J Cancer; 1999 Feb; 79(5-6):996-1002. PubMed ID: 10070903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
    Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
    In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
    Kalomenidis I; Orphanidou D; Papamichalis G; Vassilakopoulos T; Scorilas A; Rasidakis A; Papastamatiou H; Jordanoglou J; Roussos C
    Lung; 2001; 179(5):265-78. PubMed ID: 11976895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
    Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
    Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.
    Brambilla E; Gazzeri S; Lantuejoul S; Coll JL; Moro D; Negoescu A; Brambilla C
    Clin Cancer Res; 1998 Jul; 4(7):1609-18. PubMed ID: 9676834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of apoptosis-regulating proteins p53, Bcl-2, and Bax in primary resected esophageal squamous cell carcinoma.
    Hsia JY; Chen CY; Hsu CP; Shai SE; Yang SS; Chuang CY; Wang PY; Chen JT
    Neoplasma; 2001; 48(6):483-8. PubMed ID: 11949842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis-associated proteins and the development of oral squamous cell carcinoma.
    Schoelch ML; Le QT; Silverman S; McMillan A; Dekker NP; Fu KK; Ziober BL; Regezi JA
    Oral Oncol; 1999 Jan; 35(1):77-85. PubMed ID: 10211314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
    Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
    Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
    Sarbia M; Stahl M; Fink U; Willers R; Seeber S; Gabbert HE
    Clin Cancer Res; 1998 Dec; 4(12):2991-7. PubMed ID: 9865911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers.
    Groeger AM; Esposito V; De Luca A; Cassandro R; Tonini G; Ambrogi V; Baldi F; Goldfarb R; Mineo TC; Baldi A; Wolner E
    Histopathology; 2004 Jan; 44(1):54-63. PubMed ID: 14717670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients.
    Kim YC; Park KO; Kern JA; Park CS; Lim SC; Jang AS; Yang JB
    Lung Cancer; 1998 Dec; 22(3):181-90. PubMed ID: 10048471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India.
    Teni T; Pawar S; Sanghvi V; Saranath D
    Pathol Oncol Res; 2002; 8(2):109-14. PubMed ID: 12172574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
    de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
    Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas.
    Nuorva K; Soini Y; Kamel D; Autio-Harmainen H; Risteli L; Risteli J; Vähäkangas K; Pääkkö P
    Am J Pathol; 1993 Mar; 142(3):725-32. PubMed ID: 8456936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.